Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Key to changes
?
Text removedfrom 2022 Q1- Text added to 2022 Q2
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
Content analysis
?Positive | |
Negative | |
Uncertain | |
Constraining | |
Legalese | |
Litigous | |
Readability |
H.S. junior Avg
|
New words:
adalimumab, arm, COBRA, Connecticut, contemplated, contemplating, copyright, customary, endpoint, lt, marginally, meaningfully, mild, modification, nonrecurring, paused, preserve, remission, restructuring, revealed, risen, RSU, SAE, tolerated, unpaid, vacated
Removed:
activation, driven, globally, immune, innate
Valuein 2022 Q1 filing- Value in 2022 Q2 filing
Original filings
Filing view